Journal Mobile Options
Table of Contents
Vol. 6, No. 1-2, 2009
Issue release date: December 2008
Section title: Original Paper
Free Access
Neurodegenerative Dis 2009;6:23–28
(DOI:10.1159/000170883)

Plasma Urate and Progression of Mild Cognitive Impairment

Irizarry M.C.a · Raman R.c, d · Schwarzschild M.A.a · Becerra L.M.c · Thomas R.G.c, d · Peterson R.C.e · Ascherio A.b · Aisen P.S.d
aDepartment of Neurology, Massachusetts General Hospital,and bDepartment of Epidemiology, Harvard School of Public Health, Boston, Mass., cDivision of Biostatistics and Bioinformatics, Department of Family and Preventive Medicine, and dDepartment of Neurosciences, University of California San Diego, San Diego, Calif., and eDepartment of Neurology, Mayo Clinic College of Medicine, Rochester, Minn., USA
email Corresponding Author

Michael C. Irizarry, MD

WW Epidemiology, GlaxoSmithKline

5 Moore Drive, 17.2123

Research Triangle Park, NC 27709 (USA)

Tel. +1 919 483 7701, Fax +1 919 315 4947, E-Mail michael.c.irizarry@gsk.com


References

  1. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO: Prevalence of Alzheimer’s disease in a community population of older persons: higher than previously reported. JAMA 1989;262:2551–2556.
  2. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST: Practice parameter: early detection of dementia – mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133–1142.
  3. Irizarry MC, Hyman BT: Alzheimer disease therapeutics. J Neuropathol Exp Neurol 2001;60:923–928.
  4. Butterfield DA: Oxidative stress in neurodegenerative disorders. Antioxid Redox Signal 2006;8:1971–1973.
  5. Pratico D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ: Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol 2002;59:972–976.
  6. Kim TS, Pae CU, Yoon SJ, Jang WY, Lee NJ, Kim JJ, Lee SJ, Lee C, Paik IH, Lee CU: Decreased plasma antioxidants in patients with Alzheimer’s disease. Int J Geriatr Psychiatry 2006;21:344–348.
  7. Polidori MC, Mattioli P, Aldred S, Cecchetti R, Stahl W, Griffiths H, Senin U, Sies H, Mecocci P: Plasma antioxidant status, immunoglobulin G oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement Geriatr Cogn Disord 2004;18:265–270.
  8. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P: Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging 2003;24:915–919.
  9. Weisskopf MG, O’Reilly E, Chen H, Schwarzschild MA, Ascherio A: Plasma urate and risk of Parkinson’s disease. Am J Epidemiol 2007;166:561–567.
  10. Davis JW, Grandinetti A, Waslien CJ, Ross GW, White LR, Morens DM: Observations on Serum uric acid levels and the risk of idiopathic Parkinson’s disease. Am J Epidemiol 1996;144:480–484.
  11. De Lau LM, Koudstaal PJ, Hofman A, Breteler MM: Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 2005;58:797–800.
  12. Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A, Parkinson’s Study Group PRECEPT Investigators: Serum urate as a predictor of clinical and radiographic progression in Parkinson’s disease. Arch Neurol 2008; 65:716–723.
  13. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ: Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379–2388.
  14. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ: Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379–2388.
  15. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer’s disease. Am J Psychiatry 1984;141:1356–1364.
  16. Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut M, Pearlson GD, Gordon B, Jinnah HA: Serum uric acid and brain ischemia in normal elderly adults. Neurology 2007;69:1418–1423.
  17. Kim TS, Pae CU, Yoon SJ, Jang WY, Lee NJ, Kim JJ, Lee SJ, Lee C, Paik IH, Lee CU: Decreased plasma antioxidants in patients with Alzheimer’s disease. Int J Geriatr Psychiatry 2006;21:344–348.
  18. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P: Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging 2003;24:915–919.
  19. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E: No evidence for systemic oxidant stress in Parkinson’s or Alzheimer’s disease. Mov Disord 1995;10:566–573.
  20. Schretlen DJ, Inscore AB, Jinnah HA, Rao V, Gordon B, Pearlson GD: Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology 2007;21:136–140.